New data suggests that retatrutide, a dual-action medication, could represent a significant advance in weight reduction . This therapy combines the effects of a GLP-1 receptor and a GIP analog, seemingly https://sociallytraffic.com/story6644745/a-new-breakthrough-for-body-regulation